Request Demo
Last update 23 Jan 2025
Amlodipine Besylate/Fimasartan Potassium
Last update 23 Jan 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Amlodipine/fimasartan, Dukarb, Fimasartan/amlodipine + [1] |
Target |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (30 May 2016), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC27H31N7OS |
InChIKeyAMEROGPZOLAFBN-UHFFFAOYSA-N |
CAS Registry247257-48-3 |
View All Structures (2)
Related
8
Clinical Trials associated with Amlodipine Besylate/Fimasartan PotassiumNCT03991442
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of BR1010 in Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination
NCT03294070
A 24-week Open-label Clinical Trial to Assess Tolerability and Antihypertensive Effect and in Hemodynamic Parameters and Arterial Stiffness of Fimasartan 60 mg Plus Amlodipine Besylate 5 mg Given Once a Day in Patients With Hypertension in Stadiums 2/3
NCT02920047
A Randomized, Open-label, Single Dose, 3x3 Partial Replicated Crossover Study to Evaluate the Pharmacokinetics and Safety/Tolerability Between a Fixed Dose Combination of Fimasartan/Amlodipine and Co-administration of Fimasartan and Amlodipine in Healthy Male Volunteers
100 Clinical Results associated with Amlodipine Besylate/Fimasartan Potassium
Login to view more data
100 Translational Medicine associated with Amlodipine Besylate/Fimasartan Potassium
Login to view more data
100 Patents (Medical) associated with Amlodipine Besylate/Fimasartan Potassium
Login to view more data
100 Deals associated with Amlodipine Besylate/Fimasartan Potassium
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Essential Hypertension | KR | 30 May 2016 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hyperlipidemias | Phase 1 | KR | 01 Sep 2015 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free